Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v3-FR
Language French French
Date Updated 2017-04-03 2017-03-10
Drug Identification Number 02050048 02050048
Brand name APO-DOXEPIN APO-DOXEPIN
Common or Proper name DOXEPIN DOXEPIN
Company Name AA PHARMA INC AA PHARMA INC
Ingredients DOXEPIN DOXEPIN
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N06AA N06AA
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-02-14 2017-02-14
Estimated end date 2017-04-10 2017-04-10
Actual end date 2017-03-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments